What Is the Role of the Rho-ROCK Pathway in Neurologic Disorders?

Overview

Journal Neurology

Specialty Neurology

Date 2023 Sep 18

PMID 37722862

Authors

Eduardo Benarroch

Affiliations

Soon will be listed here.

Citing Articles

Insights into Calpain Activation and Rho-ROCK Signaling in Parkinson's Disease and Aging.

Gathings A, Zaman V, Banik N, Haque A Biomedicines. 2024; 12(5).

PMID: 38791036 PMC: 11117523. DOI: 10.3390/biomedicines12051074.

References

Kim H, Kim M, Mostafa M, Park J, Choi H, Kim Y . RhoA/ROCK Regulates Prion Pathogenesis by Controlling Connexin 43 Activity. Int J Mol Sci. 2020; 21(4). PMC: 7072953. DOI: 10.3390/ijms21041255. View

Cutler C, Lee S, Arai S, Rotta M, Zoghi B, Lazaryan A . Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study. Blood. 2021; 138(22):2278-2289. PMC: 8641099. DOI: 10.1182/blood.2021012021. View

Koch J, Tatenhorst L, Roser A, Saal K, Tonges L, Lingor P . ROCK inhibition in models of neurodegeneration and its potential for clinical translation. Pharmacol Ther. 2018; 189:1-21. DOI: 10.1016/j.pharmthera.2018.03.008. View

Mani S, Jindal D, Chopra H, Jha S, Singh S, Ashraf G . ROCK2 inhibition: A futuristic approach for the management of Alzheimer's disease. Neurosci Biobehav Rev. 2022; 142:104871. DOI: 10.1016/j.neubiorev.2022.104871. View

Guiler W, Koehler A, Boykin C, Lu Q . Pharmacological Modulators of Small GTPases of Rho Family in Neurodegenerative Diseases. Front Cell Neurosci. 2021; 15:661612. PMC: 8149604. DOI: 10.3389/fncel.2021.661612. View

Guo M, Zhang H, Li Y, Gu Q, Wei W, Wang Y . Fasudil inhibits the activation of microglia and astrocytes of transgenic Alzheimer's disease mice via the downregulation of TLR4/Myd88/NF-κB pathway. J Neuroimmunol. 2020; 346:577284. DOI: 10.1016/j.jneuroim.2020.577284. View

Niego B, Lee N, Larsson P, De Silva T, Au A, McCutcheon F . Selective inhibition of brain endothelial Rho-kinase-2 provides optimal protection of an in vitro blood-brain barrier from tissue-type plasminogen activator and plasmin. PLoS One. 2017; 12(5):e0177332. PMC: 5433693. DOI: 10.1371/journal.pone.0177332. View

Jeon B, Jeong E, Park S, Son H, Shin H, Lee D . The Rho-kinase (ROCK) inhibitor Y-27632 protects against excitotoxicity-induced neuronal death in vivo and in vitro. Neurotox Res. 2012; 23(3):238-48. DOI: 10.1007/s12640-012-9339-2. View

Iizuka M, Kimura K, Wang S, Kato K, Amano M, Kaibuchi K . Distinct distribution and localization of Rho-kinase in mouse epithelial, muscle and neural tissues. Cell Struct Funct. 2012; 37(2):155-75. DOI: 10.1247/csf.12018. View

10.

Tolomeu H, Fraga C . The Outcomes of Small-Molecule Kinase Inhibitors and the Role of ROCK2 as a Molecular Target for the Treatment of Alzheimer's Disease. CNS Neurol Disord Drug Targets. 2021; 21(2):188-205. DOI: 10.2174/1871527320666210820092220. View

11.

Butler M, Short N, Maniou E, Alexandre P, Greene N, Copp A . Rho kinase-dependent apical constriction counteracts M-phase apical expansion to enable mouse neural tube closure. J Cell Sci. 2019; 132(13). PMC: 6633395. DOI: 10.1242/jcs.230300. View

12.

Leong S, Faux C, Turbic A, Dixon K, Turnley A . The Rho kinase pathway regulates mouse adult neural precursor cell migration. Stem Cells. 2011; 29(2):332-43. DOI: 10.1002/stem.577. View

13.

Richardson B, Dibble C, Borikova A, Johnson G . Cerebral cavernous malformation is a vascular disease associated with activated RhoA signaling. Biol Chem. 2012; 394(1):35-42. PMC: 3677706. DOI: 10.1515/hsz-2012-0243. View

14.

Iyer M, Subramaniam M, Venkatesan D, Cho S, Ryding M, Meyer M . Role of RhoA-ROCK signaling in Parkinson's disease. Eur J Pharmacol. 2020; 894:173815. DOI: 10.1016/j.ejphar.2020.173815. View

15.

Morgan-Fisher M, Couchman J, Yoneda A . Phosphorylation and mRNA splicing of collapsin response mediator protein-2 determine inhibition of rho-associated protein kinase (ROCK) II function in carcinoma cell migration and invasion. J Biol Chem. 2013; 288(43):31229-40. PMC: 3829433. DOI: 10.1074/jbc.M113.505602. View

16.

Wu J, Li J, Hu H, Liu P, Fang Y, Wu D . Rho-kinase inhibitor, fasudil, prevents neuronal apoptosis via the Akt activation and PTEN inactivation in the ischemic penumbra of rat brain. Cell Mol Neurobiol. 2012; 32(7):1187-97. PMC: 11498490. DOI: 10.1007/s10571-012-9845-z. View

17.

Zanin-Zhorov A, Weiss J, Nyuydzefe M, Chen W, Scher J, Mo R . Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism. Proc Natl Acad Sci U S A. 2014; 111(47):16814-9. PMC: 4250132. DOI: 10.1073/pnas.1414189111. View

18.

Gu Q, Yu J, Wu H, Li Y, Liu C, Feng L . Therapeutic effect of Rho kinase inhibitor FSD-C10 in a mouse model of Alzheimer's disease. Exp Ther Med. 2018; 16(5):3929-3938. PMC: 6176147. DOI: 10.3892/etm.2018.6701. View

19.

Moon S, Zheng Y . Rho GTPase-activating proteins in cell regulation. Trends Cell Biol. 2002; 13(1):13-22. DOI: 10.1016/s0962-8924(02)00004-1. View

20.

Shi J, Surma M, Zhang L, Wei L . Dissecting the roles of ROCK isoforms in stress-induced cell detachment. Cell Cycle. 2013; 12(10):1492-500. PMC: 3680529. DOI: 10.4161/cc.24699. View